Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
Carolyn Wasserheit(Columbia University Irving Medical Center), J Speyer, Abraham Chachoua(New York University), Anne Zeleniuch‐Jacquotte(New York University), Ruth Oratz(NYU Langone Health), Ronald H. Blum(Columbia University Irving Medical Center), J Wernz, Andrea Downey(University of New Mexico), Joan Sorich, H. S. Hochster(Sarah Cannon), Andrea Frazein
Cited by 87
Related Papers
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
Dietary Fiber Intake and Risk of Colorectal Cancer
|JAMA|2005|467